Pfiz­er vet Ger­mano makes quick ex­it from In­trex­on as hands-on bil­lion­aire Kirk re­or­ga­nizes biotech

When Geno Ger­mano left a se­nior post at Pfiz­er and lat­er signed on as pres­i­dent of In­trex­on 10 months ago, he start­ed down a path …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.